Think about this . . . if you were a care giver . . . would you want to be associated with a company that cannot even fund itself by reasonably means? This DRIO company has lacked adequate marketing ability and budget, from its start.
For a vaunted Israeli company . . . DRIO has hardly performed well even in its own country (apparently). Where is the news of such and one must imagine (without looking it up), there must be 10,000s of diabetic persons in that country. Where are the user sales figures and revs for that country?
It is looking much like we retail USA investors have gotten way ahead of ourselves, in our proof 'of-the-pudding'?
Unless, we get FDA Approval by say March, 2015 (which is now seemingly doubtful also), or another private placement happens (as a new R/Split would be rather out-of-the-question) . . . we are 'stuck' waiting for a new partner/buyout or the company bounces along forever at low-penny territory, or DRIO goes private, or BK?
One might ask the company, how many persons are in your sales force?
Going to conferences and 'cold-mailings' to USA doctors, and Facebook hits does not give me great confidence, we shall succeed.
With the bad PR this company has dropped on its retail investors (that are left) to date, how can we move the stock price up much?
A drop from $2.00+ stock price to .10 range?
Sounds like plain and simple 'Candle-smoke' (and not the good stuff) . . . to at least me. Technical Signals . . . ah . . . who is going to buy this up to say .35?
The MM? Surely. With 'magic' shares.
Think . . . not one good review of CC and DRIO vetted to a live press release, naming an interested party. We really need some solid orders announcements from already approved marketing countries.
And, I do not see (at this point) a tremendous holiday seasonal buying effect to transpire, for the world's economies . . . we are looking like a repeat of 1930s; with food stamps and cell phone free-me-ium VGs replacing the soup kitchens and loudspeaker music and corner-curb preaching.
Will DRIO reader device be heavily ordered, as a replacement for existing diabetic blood readers, in next 2-3 months?
Whatever could the tech charts . . . tell our fallen shoulders?
Bye-the-way . . .some company is now claiming it has Ebola mobile hand-held reader device that can deliver results in ten minutes . . . a miniature lab instrument for $5K to start with, sometime in latter 2015. IF, such a thing is feasible, what of other 'bodily fluids' reader options, DRIO has yet to bring about?
